Theophylline

NDC 64380-244 · Strides Pharma Science Limited

Generic nameTheophylline

Dosage formTABLET, EXTENDED RELEASE

RouteORAL

Active ingredient(s)THEOPHYLLINE ANHYDROUS

Strength450 mg/1

Pharmacologic classMethylxanthine [EPC], Xanthines [CS]

Marketing categoryANDA

Packages

64380-244-01 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64380-244-01)

FDA lists these products with the same active ingredient.

52244-200 — theophylline anhydrous, 52244-300 — theophylline anhydrous, 52244-400 — theophylline anhydrous, 60219-2045 — theophylline, 60219-2046 — theophylline, 62135-457 — Theophylline, 62135-556 — Theophylline, 62332-025 — Theophylline, 62332-026 — Theophylline, 64380-243 — Theophylline, 68462-356 — Theophylline, 68462-380 — Theophylline, 68462-721 — Theophylline, 68462-722 — Theophylline, 68999-556 — Theophylline, 69367-414 — Theophylline Anhydrous, 69367-415 — Theophylline Anhydrous, 69452-267 — Theophylline, 70771-1782 — Theophylline, 70771-1783 — Theophylline, +22 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.